Dermavant Sciences
Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant's focus is to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development. The company's robust medical dermatology pipeline includes both late-stage and earlier-stage-development product candidates the company believes could address important immuno-dermatological conditions, including psoriasis, atopic dermatitis, vitiligo, primary focal hyperhidrosis, and acne.
Last updated on
About Dermavant Sciences
Founded
2016Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$200MCategory
Industry
BiotechnologyLocation
City
Long BeachState
CaliforniaCountry
United StatesTech Stack (63)
Widgets
OneTrust
CookiePro
Zoom Video Conferencing
Slack
Google Font API
Wordpress Plugins
Contact Form 7
Google Tag Manager
reCAPTCHA
Adobe Sign
DocuSign
WP Store Locator
US Privacy User Signal Mechanism
CrUX Dataset
Recent Posts Widget With Thumbnails
Global Privacy Control
Cloudflare Radar
Unsplash
Shutterstock
YouTube IFrame Upload
EWWW Image Optimizer